A prominent consumer advocacy group and an FDA advisory committee chair filed a citizen petition on Thursday (March 21) demanding FDA slap an immediate moratorium on the approval of new opioids until it revamps its regulation and review of new opioids as recommended by the National Academies of Sciences, Engineering, and Medicine in 2017. The academies' study, requested by FDA, called for a new systems approach for analyzing the benefits and risks of opioid medication that considers the effects of...